Pharma BD Deal Intelligence
Astellas Pharma Inc. / OSI Pharmaceuticals
2010 · Acquisition/Merger · $4.0B · Complete
Announcement Sentiment
63
Positive
Outcome Score
51
Mixed — partial payoff, real shortfalls.
Astellas acquired OSI Pharmaceuticals for $4B.
Did it work? Outcome assessment
Astellas / OSI Pharmaceuticals: Partially Achieved (Score: 53/100)
Strategic verdict
Partially Achieved
Assessment window: 5yr post-close.
Key facts
- Announced May 16, 2010
- Closed Jun 09, 2010
- Deal value $4.0B
- Deal type Acquisition/Merger
- Therapeutic area Oncology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals